Alaunos Therapeutics(TCRT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TCRT Alaunos Therapeutics

休市中 11-06 16:00:00 EST

1.74

-0.10

-5.43%

盘后1.82

+0.08+4.60%

19:27 EST

最高1.89	最低1.74	成交量10.15万
今开1.79	昨收1.84	日振幅8.15%
总市值442.05万	流通市值209.43万	总股本254.05万
成交额18.45万	换手率8.43%	流通股本120.36万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TCRT","market":"US","secType":"STK","nameCN":"Alaunos Therapeutics","latestPrice":1.74,"timestamp":1793998800000,"preClose":1.84,"halted":0,"volume":101458,"hourTrading":{"tag":"盘后","latestPrice":1.82,"preClose":1.74,"latestTime":"19:27 EST","volume":6643,"amount":12109.5196,"timestamp":1794011266917,"change":0.08,"changeRate":0.045977,"amplitude":0.08046},"delay":0,"changeRate":-0.05434782608695657,"floatShares":1203600,"shares":2540500,"eps":-1.768422,"marketStatus":"休市中","change":-0.1,"latestTime":"11-06 16:00:00 EST","open":1.79,"high":1.89,"low":1.74,"amount":184524.1300294,"amplitude":0.081522,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.768422,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"listingDate":1158897600000,"exchange":"NASDAQ","adjPreClose":1.84,"preHourTrading":{"tag":"盘前","latestPrice":1.82,"preClose":1.84,"latestTime":"08:53 EST","volume":1873,"amount":3362.1142279,"timestamp":1793973239285,"change":-0.02,"changeRate":-0.01087,"amplitude":0.130598},"postHourTrading":{"tag":"盘后","latestPrice":1.82,"preClose":1.74,"latestTime":"19:27 EST","volume":6643,"amount":12109.5196,"timestamp":1794011266917,"change":0.08,"changeRate":0.045977,"amplitude":0.08046},"volumeRatio":0.343879,"impliedVol":0.01,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TCRT","defaultTab":"news","newsList":[{"id":"1193798011","title":"Alaunos Therapeutics宣布按纳斯达克规则进行市价注册直接发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1193798011","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193798011?lang=zh_cn&edition=full","pubTime":"2026-09-18 21:01","pubTimestamp":1789736478,"startTime":"0","endTime":"0","summary":"Alaunos Therapeutics, Inc.今日正式宣告，其已敲定一项注册直接发行的定价方案。此番发行将严格遵循纳斯达克的相关规则，采取按市价（at-the-market）的方式推进。这一举措标志着公司在资本市场运作上迈出了关键一步，备受投资者关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TCRT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185579747","title":"Alaunos Therapeutics：Aln1003治疗组动物经体脂校正后HOMA-IR评分显著降低","url":"https://stock-news.laohu8.com/highlight/detail?id=1185579747","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185579747?lang=zh_cn&edition=full","pubTime":"2026-05-18 20:01","pubTimestamp":1779105680,"startTime":"0","endTime":"0","summary":"Alaunos Therapeutics公司公布的研究数据显示，在经体脂调整后，接受其候选疗法Aln1003治疗的实验动物，其胰岛素抵抗稳态模型评估（HOMA-IR）评分出现显著下降。这一结果表明Aln1003在改善胰岛素敏感性方面可能具有潜在效用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TCRT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174461301","title":"Alaunos公布Aln1003临床前数据：在饮食诱导肥胖模型中显示对胰岛素抵抗相关生物标志物及肝脏组织学的影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1174461301","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174461301?lang=zh_cn&edition=full","pubTime":"2026-05-18 20:00","pubTimestamp":1779105627,"startTime":"0","endTime":"0","summary":"Alaunos Therapeutics报告了其候选药物Aln1003的临床前研究数据。该数据显示，在饮食诱导的肥胖模型中，Aln1003对胰岛素抵抗相关的生物标志物以及肝脏组织学产生了积极影响。\n研究结果表明，Aln1003干预后，与胰岛素敏感性相关的关键生物标志物水平出现了有利变化。同时，肝脏组织的病理学检查也显示出改善迹象。这些发现为Aln1003在代谢性疾病领域的潜在应用提供了新的科学依据。\n该临床前数据进一步支持了Aln1003的开发路径，后续研究将深入探索其作用机制与治疗潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TCRT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513725215","title":"Alaunos Therapeutics, Inc.盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513725215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513725215?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:06","pubTimestamp":1740161195,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时06分，Alaunos Therapeutics, Inc.股票出现波动，股价快速上涨5.24%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Osr Holdings, Inc.涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为254.90%、243.33%、135.46%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Osr Holdings Inc C/Wts 09/02/2028 ，振幅分别为76.52%、70.25%、57.50%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222020635988e0e5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222020635988e0e5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRT","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509209863","title":"Alaunos Therapeutics, Inc.盘中异动 大幅拉升6.18%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509209863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509209863?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:37","pubTimestamp":1738859863,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时37分，Alaunos Therapeutics, Inc.股票出现波动，股价大幅拉升6.18%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Transcode Therapeutics, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为5845.61%、1530.73%、155.11%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Palatin Technologies, Inc.，振幅分别为125.58%、53.02%、49.54%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003743abc4eeec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003743abc4eeec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRT","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508468879","title":"Alaunos Therapeutics, Inc.盘中异动 股价大涨5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508468879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508468879?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:02","pubTimestamp":1738681372,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时02分，Alaunos Therapeutics, Inc.股票出现异动，股价快速上涨5.92%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Azitra Inc、Evaxion Biotech As、Regulus Therapeutics Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1381.30%、843.15%、212.19%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Briacell Therapeutics Corp C/Wts 24/02/2025，振幅分别为58.24%、49.88%、40.00%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042302539617dceb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042302539617dceb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRT","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507954584","title":"Alaunos Therapeutics, Inc.盘中异动 快速下跌8.33%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507954584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507954584?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:41","pubTimestamp":1738082472,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时41分，Alaunos Therapeutics, Inc.股票出现波动，股价大幅下跌8.33%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Silexion Therapeutics Corp、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Transcode Therapeutics, Inc.涨幅较大，Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4442.85%、3347.63%、2552.58%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Transcode Therapeutics, Inc.，振幅分别为177.30%、122.16%、102.05%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129004112abbb8092&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129004112abbb8092&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRT","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505287670","title":"Alaunos Therapeutics, Inc.盘中异动 下午盘股价大涨6.43%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505287670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505287670?lang=zh_cn&edition=full","pubTime":"2025-01-24 04:01","pubTimestamp":1737662512,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时01分，Alaunos Therapeutics, Inc.股票出现异动，股价大幅拉升6.43%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Transcode Therapeutics, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为7211.57%、6905.46%、896.79%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Transcode Therapeutics, Inc.，振幅分别为948.57%、172.73%、142.40%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124040152960e8066&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124040152960e8066&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TCRT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501294739","title":"Alaunos Therapeutics, Inc.盘中异动 大幅跳水6.34%报1.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501294739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501294739?lang=zh_cn&edition=full","pubTime":"2025-01-07 03:02","pubTimestamp":1736190130,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日03时02分，Alaunos Therapeutics, Inc.股票出现异动，股价大幅下挫6.34%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Scisparc Ltd.、Unity Biotechnology, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为1680.16%、383.89%、177.28%，振幅较大的相关个股有Scisparc Ltd.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为176.15%、106.67%、92.16%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010703021195faa2a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010703021195faa2a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TCRT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495377614","title":"Alaunos Therapeutics, Inc.盘中异动 早盘股价大跌7.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495377614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495377614?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:30","pubTimestamp":1735655456,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时30分，Alaunos Therapeutics, Inc.股票出现波动，股价急速跳水7.58%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，知临集团、Onconetix, Inc.、Eyenovia, Inc.涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为858.99%、623.56%、131.26%，振幅较大的相关个股有知临集团、Onconetix, Inc.、Eyenovia, Inc.，振幅分别为32.47%、27.46%、18.27%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231223056ab9981cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231223056ab9981cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TCRT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492179578","title":"Alaunos Therapeutics, Inc.盘中异动 股价大涨5.00%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492179578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492179578?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:32","pubTimestamp":1734618755,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时32分，Alaunos Therapeutics, Inc.股票出现异动，股价急速上涨5.00%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.76%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mesoblast Ltd涨幅较大，Phio Pharmaceuticals Corp.、Elevai Labs, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为406.04%、311.19%、309.29%，振幅较大的相关个股有奥麦罗制药、Allakos Inc.、Elevai Labs, Inc.，振幅分别为15.15%、13.08%、12.56%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223235a1fb58ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223235a1fb58ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TCRT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491374120","title":"Alaunos Therapeutics, Inc.盘中异动 早盘急速下挫5.29%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491374120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491374120?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:46","pubTimestamp":1734104791,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时46分，Alaunos Therapeutics, Inc.股票出现异动，股价急速跳水5.29%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Cardiff Oncology, Inc.、Oculis Holding Ag C/Wts 06/03/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Aptevo Therapeutics Inc.、Palisade Bio, Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为60.12%、57.06%、34.00%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为43.30%、43.12%、39.33%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213234631ab75b003&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213234631ab75b003&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TCRT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488117946","title":"Alaunos Therapeutics, Inc.盘中异动 早盘急速拉升7.54%报2.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488117946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488117946?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:35","pubTimestamp":1733236558,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时35分，Alaunos Therapeutics, Inc.股票出现波动，股价大幅拉升7.54%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Cytomx Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为130.42%、69.94%、55.25%，振幅较大的相关个股有Coherus Biosciences, Inc.、万春医药、Cabaletta Bio, Inc.，振幅分别为24.09%、14.79%、12.35%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223558abf2face&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223558abf2face&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TCRT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488677371","title":"Alaunos Therapeutics, Inc.盘中异动 早盘快速上涨6.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488677371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488677371?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:31","pubTimestamp":1733149886,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时31分，Alaunos Therapeutics, Inc.股票出现波动，股价快速拉升6.59%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Purple Biotech Ltd、Senti Biosciences, Inc.、Revelation Biosciences, Inc.较为活跃，换手率分别为648.87%、643.18%、201.68%，振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Cabaletta Bio, Inc.，振幅分别为27.31%、11.92%、10.73%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223126a2669863&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223126a2669863&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRT","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485290410","title":"Alaunos Therapeutics, Inc.盘中异动 大幅上涨5.17%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485290410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2485290410?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:50","pubTimestamp":1732301402,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日02时50分，Alaunos Therapeutics, Inc.股票出现异动，股价急速拉升5.17%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Replimune Group, Inc.、Exicure, Inc.、奥麦罗制药涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1890.77%、156.08%、98.30%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Virpax Pharmaceuticals, Inc.，振幅分别为82.83%、77.41%、72.75%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123025002abd7f9e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123025002abd7f9e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRT","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485417345","title":"Alaunos Therapeutics, Inc.盘中异动 大幅上涨5.16%报2.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485417345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2485417345?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:06","pubTimestamp":1732208785,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时06分，Alaunos Therapeutics, Inc.股票出现波动，股价急速上涨5.16%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Cidara Therapeutics, Inc.、Briacell Therapeutics Corp.、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为915.49%、497.88%、369.24%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为162.20%、81.04%、76.33%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112201062598e43f99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112201062598e43f99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRT","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483344884","title":"Alaunos Therapeutics, Inc.盘中异动 早盘急速拉升5.33%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483344884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483344884?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:46","pubTimestamp":1731509218,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时46分，Alaunos Therapeutics, Inc.股票出现异动，股价快速拉升5.33%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Lexeo Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为343.38%、203.16%、90.84%，振幅较大的相关个股有Lexeo Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Immunoprecise Antibodies Ltd.，振幅分别为43.36%、36.31%、26.81%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322465998e42610&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322465998e42610&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TCRT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2477861383","title":"Alaunos Therapeutics, Inc.盘中异动 早盘大幅跳水5.31%报2.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477861383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2477861383?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:12","pubTimestamp":1729519953,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时12分，Alaunos Therapeutics, Inc.股票出现波动，股价急速下挫5.31%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Genprex, Inc.、Biovie Inc.、Gri Bio, Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为2732.15%、2387.74%、851.56%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ，振幅分别为183.29%、157.02%、116.08%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122123398e3d8bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122123398e3d8bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRT","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2474225047","title":"Alaunos Therapeutics, Inc.盘中异动 早盘股价大跌5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474225047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2474225047?lang=zh_cn&edition=full","pubTime":"2024-10-09 21:37","pubTimestamp":1728481044,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日21时37分，Alaunos Therapeutics, Inc.股票出现波动，股价急速跳水5.93%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Kezar Life Sciences, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Gri Bio, Inc.较为活跃，换手率分别为628.21%、93.94%、40.03%，振幅较大的相关个股有Cue Biopharma, Inc.、Inhibikase Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为39.02%、22.69%、12.50%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100921372598e3b765&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100921372598e3b765&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRT","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2472795072","title":"Alaunos Therapeutics, Inc.股价飙升11.68% 市值涨1.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472795072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2472795072?lang=zh_cn&edition=full","pubTime":"2024-10-04 22:17","pubTimestamp":1728051458,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日22时17分，Alaunos Therapeutics, Inc.股票出现波动，股价急速拉升11.68%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Aditxt, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为13661.32%、45.63%、32.88%，振幅较大的相关个股有Aditxt, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Sagimet Biosciences Inc. - Series A，振幅分别为47.42%、40.36%、24.51%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004221738ab67bdfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004221738ab67bdfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRT","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alaunos.com","stockEarnings":[{"period":"1week","weight":-0.1077},{"period":"1month","weight":1.0761},{"period":"3month","weight":-0.1256},{"period":"6month","weight":-0.3256},{"period":"1year","weight":-0.2927},{"period":"ytd","weight":-0.4613}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alaunos Therapeutics, Inc.最初于1998年9月在科罗拉多州注册成立，后来在特拉华州重新注册成立。该公司是一家临床前阶段的生物制药公司，专注于开发用于治疗肥胖症及相关代谢紊乱（包括代谢功能障碍相关的脂肪肝）的新型口服小分子疗法。该项目旨在开发一种差异化的、非激素、非肠促胰岛素的治疗方法，这与 GLP-1 类药物等激素疗法截然不同。","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":0.14745},{"month":2,"riseRate":0.52381,"avgChangeRate":0.051044},{"month":3,"riseRate":0.380952,"avgChangeRate":-0.036602},{"month":4,"riseRate":0.571429,"avgChangeRate":0.020468},{"month":5,"riseRate":0.47619,"avgChangeRate":0.064714},{"month":6,"riseRate":0.47619,"avgChangeRate":0.061739},{"month":7,"riseRate":0.238095,"avgChangeRate":-0.074701},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.068882},{"month":9,"riseRate":0.571429,"avgChangeRate":0.025527},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.008105},{"month":11,"riseRate":0.590909,"avgChangeRate":0.041662},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.113574}],"exchange":"NASDAQ","name":"Alaunos Therapeutics","nameEN":"Alaunos Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alaunos Therapeutics(TCRT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Alaunos Therapeutics(TCRT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Alaunos Therapeutics,TCRT,Alaunos Therapeutics股票,Alaunos Therapeutics股票老虎,Alaunos Therapeutics股票老虎国际,Alaunos Therapeutics行情,Alaunos Therapeutics股票行情,Alaunos Therapeutics股价,Alaunos Therapeutics股市,Alaunos Therapeutics股票价格,Alaunos Therapeutics股票交易,Alaunos Therapeutics股票购买,Alaunos Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alaunos Therapeutics(TCRT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Alaunos Therapeutics(TCRT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}